| Literature DB >> 23536890 |
Wataru Fujii1, Kiyoshi Kano, Koji Sugiura, Kunihiko Naito.
Abstract
Zinc finger nuclease (ZFN) is a useful tool for endogenous site-directed genome modification. The development of an easier, less expensive and repeatedly usable construction method for various sequences of ZFNs should contribute to the further widespread use of this technology. Here, we establish a novel construction method for ZFNs. Zinc finger (ZF) fragments were synthesized by PCR using short primers coding DNA recognition helices of the ZF domain. DNA-binding domains composed of 4 to 6 ZFs were synthesized by overlap extension PCR of these PCR products, and the DNA-binding domains were joined with a nuclease vector by TA cloning. The short primers coding unique DNA recognition helices can be used repeatedly for other ZFN constructions. By using this novel OLTA (OverLap extension PCR and TA-cloning) method, arbitrary ZFN vectors were synthesized within 3 days, from the designing to the sequencing of the vector. Four different ZFN sets synthesized by OLTA showed nuclease activities at endogenous target loci. Genetically modified mice were successfully generated using ZFN vectors constructed by OLTA. This method, which enables the construction of intended ZFNs repeatedly and inexpensively in a short period of time, should contribute to the advancement of ZFN technology.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23536890 PMCID: PMC3607563 DOI: 10.1371/journal.pone.0059801
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Experimental schemes for vector construction.
(A) Composition of the platform vector used for ZFN construction. (B) Construction procedures for ZFN vectors by OLTA. In this figure, construction of a DNA-binding domain composed of 4 ZFs is shown as an example. Three partial ZF fragments were synthesized by the 1st PCR with the primer sets shown in Table 2 and they were combined by overlap extension PCR (2nd PCR) and amplified by 3rd PCR; then the DNA-binding domain was joined with the platform vector by TA cloning. (C) A scheme showing constructs of in vitro transcribed ZFN mRNA and in vivo translated ZFN protein, and ZFN binding with target DNA; Gli3 target site is shown in this figure for example.
Primer sets for 1st PCR.
| Target DNA triplet | DNA-recognition-helix sequence | Forward Primer | Reverse Primer | ||
| GAA | QSGNLAR | 5′- | CaaTCGGgTaacCTTgCCCGCCATATCCG (7) | 5′- | GGCGGGCAAGgTTAcCCGAttGACTGAAG (4) |
| GAC | DRSNLTR | 5′- | gaCagGagTaatCTTACCCGCCATATCCG (9) | 5′- | GGCGGGtAAGATTActCcTGtcACTGAAG (6) |
| GAG | RSDNLAR | 5′- | CGCTCGGATaatCTTgCCCGCCATATCCG (4) | 5′- |
|
| GAT | TSGNLVR | 5′- | acCTCGGgTaatCTTgtCCGCCATATCCG (8) | 5′- | GGCGGaCAAGATTAcCCGAGgaACTGAAG (4) |
| GCA | QSGDLTR | 5′- | CaaTCGGgTGatCTTACCCGCCATATCCG (5) | 5′- | GGCGGGtAAGATcAcCCGAttGACTGAAG (4) |
| GCC | DCRDLAR | 5′- | gaCTGcagaGacCTTgCCCGCCATATCCG (9) | 5′- | GGCGGGCAAGgTctctgcAGtaACTGAAG (9) |
| GCG | RSDDLQR | 5′- | CGCTCGGATGacCTTcaaCGCCATATCCG (5) | 5′- | GGCGttgAAGgTcATCCGAGCGACTGAAG (5) |
| GGA | QSGHLQR | 5′- | CagTCGGgTcatCTTcaaCGCCATATCCG (9) | 5′- | GGCGttgAAGATgAcCCGActGACTGAAG (7) |
| GGG | RSDHLSR | 5′- | CGCTCGGATcacCTTtCCCGCCATATCCG (4) | 5′- | GGCGGGaAAGgTgATCCGAGCGACTGAAG (3) |
| GGT | TSGHLVR | 5′- | acCTCGGgTcacCTTgtCCGCCATATCCG (8) | 5′- | GGCGGaCAAGgTgAcCCGAGgtACTGAAG (6) |
| GTC | DPGALVR | 5′- | gaCcCGGgTGCGCTTgtCCGCCATATCCG (6) | 5′- | GGCGGaCAAGcgcAtCCGgGtcACTGAAG (8) |
| GTG | RSDALTR | 5′- |
| 5′- | GGCGGGtAAGcgcATCCGAGCGACTGAAG (4) |
| GTT | TSGSLVR | 5′- | acCTCGGgTtCGtTagtCaGaCATATCCG (10) | 5′- | GtCtGaCtAacgaATCCGAGgtACTGAAG (10) |
| AAG | RKDNLKN | 5′- | CGCaaGGATaacCTTAaaaaCCATATCCG (9) | 5′- | GGtttttAAGgTTATCCttGCGACTGAAG (8) |
| ACT | THLDLIR | 5′- | acCcacctTGatCTTAtCCGCCATATCCG (10) | 5′- | GGCGGatAAGATcAaggtgGgtACTGAAG (10) |
| AGA | QLAHLRA | 5′- | CaaTtGGcTcacCTTcgCgcCCATATCCG (11) | 5′- | GGgcGcgAAGgTgAgCCaAttGACTGAAG (10) |
| AGG | RSDHLTN | 5′- | CGCTCGGATcacCTTACCaaCCATATCCG (5) | 5′- | GGttGGtAAGgTgATCCGAGCGACTGAAG (5) |
| ATG | RRDELNV | 5′- | CGCcgGGATGaGCTTAACgtCCATATCCG (5) | 5′- | GGacGttAAGcTcATCCcgGCGACTGAAG (8) |
| CTG | RNDALTE | 5′- | CGCaatGAcGCGCTTACCgaaCATATCCG (7) | 5′- | GttcGGtAAGcgcgTCattGCGACTGAAG (11) |
| TGA | QAGHLAS | 5′- | CaagCGGgTcatCTTgCCaGCCATATCCG (9) | 5′- | GGCtGGCAAGATgAcCCGcttGACTGAAG (6) |
| TGG | RSDHLTT | 5′- | CGCagtGATcacCTTACCacCCATATCCG (8) | 5′- | GGgtGGtAAGgTgATCactGCGACTGAAG (8) |
The capital letters and small letters show same and different nucleotides compared to the zinc-finger-template vector.
Number of different nucleotides compared to the zinc-finger-template vector.
ZFN target sequences and ZF alignment of each ZFN.
| Gene | Target Sequence | ZF1 | ZF2 | ZF3 | ZF4 | ZF5 | ZF6 | |
|
| Left |
| GCC | TGG | CTG | GAG | ||
| Right |
| GAA | GAG | TGA | GAC | |||
|
| Left |
| GCA | GTT | GGA | ACT | AAG | AGA |
| Right |
| GTC | GGA | GCG | TGG | |||
|
| Left |
| TGG | GGT | TGA | GCG | GCA | |
| Right |
| GGG | AGG | AGA | ATG | GGT | ||
|
| Left |
| GAC | GTG | GGT | GCG | ||
| Right |
| GTC | GAT | GAA | GAG | |||
Overlap-extension PCR conditions.
| PCR mixture | PCR conditions | |
|
| ||
| 5 µl of 10X Ex Taq Buffer | 95°C, 2 min | |
| 4 µl of dNTP Mixture (2.5 mM each) | 95°C, 15 sec | X 40 cycles |
| 2.5 µl of 10 µM Forward primer | 54°C, 15 sec | |
| 2.5 µl of 10 µM Reverse primer | 72°C, 15 sec | |
| 1 µl of 100 µg/ml Template vector | 72°C, 5 min | |
| 0.5 µl of 5 U/µl Ex Taq | ||
| 34.5 µl of Ultra pure water | ||
|
| ||
| 5 µl of 10X Ex Taq Buffer | 95°C, 2 min | |
| 4 µl of dNTP Mixture (2.5 mM each) | 94°C, 30 sec | X 15 cycles |
| 0.5 µl of 5 U/µl Ex Taq | 68°C, 30 sec | |
| 1st PCR amplicons (10 µg/ml each) | 68°C, 5 min | |
| 0.5 µl each of ZF1-ZF2 and ZF3-ZF4 amplicons and 1.5 µl of ZF2-3 amplicon (4ZF) | ||
| or 0.5 µl each of ZF1-ZF2 and ZF4-ZF5 amplicons and 1.5 µl each of ZF2-3 and ZF3-4 amplicons (5ZF) | ||
| or 0.5 µl each of ZF1-ZF2, ZF2-ZF3, ZF4-ZF5 and ZF5-ZF6 amplicons and 1.5 µl of ZF3-4 amplicon (6ZF) | ||
| Adjust to 50 µl with Ultra pure water | ||
|
| ||
| 5 µl of 10X Ex Taq Buffer | 95°C, 2 min | |
| 4 µl of dNTP Mixture (2.5 mM each) | 94°C, 30 sec | X 25 cycles |
| 2.5 µl of 10 µM ZF1 Forward primer | 68°C, 30 sec | |
| 2.5 µl of 10 µM ZF4 (4ZF), ZF5 (5ZF) or ZF6 (6ZF) Reverse primer | 68°C, 5 min | |
| 0.5–1 µl of 2nd PCR reacted mixture | ||
| 0.5 µl of 5 U/µl Ex Taq | ||
| Adjust to 50 µl with Ultra pure water | ||
Genomic PCR conditions.
| PCR mixture | Reaction conditions | |
| 2 µl of 10X Ex Taq Buffer | 95°C, 5 min | |
| 2.4 µl of dNTP Mixture (2.5 mM each) | 94°C, 30 sec | X 40 cycles for 2-cell embryo or X 35 cycles for tale DNA |
| 1.5 µl of 10 µM Forward primer | 57°C, 30 sec | |
| 1.5 µl of 10 µM Reverse primer | 72°C, 40 sec | |
| 10 µl of embryo lysate or 1 µl of tale DNA solution | 72°C, 5 min | |
| 0.6 µl of 5 U/ml Ex Taq | ||
| 12 µl of UltraPure Water | ||
Primer sets for genomic PCR.
| Target gene | Primor sequence | ||
|
| Forward | 5′- |
|
| Reverse | 5′- |
| |
|
| Forward | 5′- |
|
| Reverse | 5′- |
| |
|
| Forward | 5′- |
|
| Reverse | 5′- |
| |
|
| Forward | 5′- |
|
| Reverse | 5′- |
| |
Figure 2The construction and expression of ZFNs.
(A) Three-step PCR for the construction of DNA-binding domain of ZFs. PCR products for each PCR step for 6-finger ZF (left-ZF of Rosa26), 5-finger ZF (left-ZF of Il2rg), and 4-finger ZF (left-ZF of Gli3) are shown. Arrows indicate the intended base pairs of PCR products. (B) Construction efficiencies of left- and right-ZFNs for 4 target loci. (C, D) The expression of constructed ZFN in mouse zygotes. ZFN mRNA at 200 µg/ml (100 µg/ml each for right- and left-ZFNs) were injected into the cytoplasm of mouse zygotes and after 4 h, ZFN protein expression was confirmed by immunoblotting (C) and immunocytochemistry (D) with anti-Flag antibody. Alpha-tubulin immunoblotting is shown as the internal control, and DNA was stained by propidium iodide.
Time schedule for OLTA.
| Procedure | Time required (h) |
| Day 1 | |
| 1st PCR | 1 |
| Gel purification | 1 |
| 2nd PCR | ] 1 |
| 3rd PCR | |
| Gel purification | 1.5 |
| Ligation | 0.5–1 |
| Transformation, Plating | 0.5 |
| Day 2 | |
| Colony PCR | 2 |
| Gel electrophorasis | 1 |
| Culture of candidate colonies | O/N |
| Day 3 | |
| Plasmid DNA isolation | 1 |
| Sequencing reaction | 6 |
Overnight.
Figure 3Functional analysis of the constructed ZFNs in preimplantation mouse embryos.
Each of ten 2-cell embryos injected with 20 µg/ml of ZFN mRNAs (10 µg/ml each for right- and left-ZFNs) were subjected to T7 endonuclease I assay. Arrows indicate the mismatch-digestion fragments derived from ZFN-induced genome mutation at the target loci. The other fragments digested at the provable SNP sites are indicated by arrowheads.
ZFN-induced site-directed mutations in mouse 2-cell embryos.
| Target gene | ZFN concentration (µg/ml) | No. of embryos | Sequence of target site | Modification (S, D, I) | Number of embryos | |
| Examined | Mutated | |||||
|
| 200 | 16 | 3 |
| WT | 13 |
| AGCCCCACAGCTCTtCGGCGACTGAGAGGAAG | 1 S | 1 | ||||
| AGGCCCCCAGCTCT–GCGACTGAGAGGAAG | 3 D | 1 | ||||
| AG–––––––––– | 142 D | 1 | ||||
| 20 | 32 | 3 |
| WT | 29 | |
| AGGCCCACAGCTCT-CGGCGACTGAGAGGAAG | 1 D | 1 | ||||
| AGG–––––-GACTGAGAGGAAAG | 16D | 1 | ||||
| AGGCCCACAGtTtT–GCGACTGAGAGGAAG | 3 D, 2 S | 1 | ||||
|
| 200 | 9 | 9 |
| WT | 0 |
| CTGCAACTCCAGTCTTTCTAGA–TGGGCGGGAGTCT | 3 D | 4 | ||||
| CTGCAACTCCAG––––ATGGtCGGGAGTCT | 12 D | 1 | ||||
| CTGCAACTCCAGGCTTTCTA–––––-CT | 16 D | 1 | ||||
| CTGCAACTCCAG––––––––TCT | 23 D | 1 | ||||
| CTGCAAC––––––––––- | 122 D | 1 | ||||
| –––––––––––AGTCT | 146 D | 1 | ||||
| 20 | 31 | 5 |
| WT | 26 | |
| CTGCAACTCCAGTCTTTCTAGAA–TGGGCGGGAGTCT | 2 D | 1 | ||||
| CTGCAACTCCAGTCTTTCTAGAA–GGGCGGGAGTCT | 3 D | 1 | ||||
| CTGCAACTCCAGTCTTTCTAGA–TGGGCGGGAGTCT | 3 D | 2 | ||||
| CTGCAACTCCAGTCTTT––-ATGGGCGGGAGTCT | 7 D | 1 | ||||
|
| 20 | 30 | 4 |
| WT | 26 |
| ACCAACCTCACGCTGCAC–AGGTATGAGAAGGGGGA | 3 D | 1 | ||||
| ACCAACCTCACGCTGCAC–-GGTATGAGAAGGGGGA | 4 D | 1 | ||||
| ACCAACCTCACGCTGCA–––TGAGAAGGGGGA | 9 D | 1 | ||||
| ACCCACCTCACGCTCCAtcacaaccttttgcctGGGGA | 16 I | 1 | ||||
|
| 20 | 39 | 3 |
| WT | 36 |
| GGTCCACACCCGCCC-AGGAGGAAGATGTCA | 1 D | 1 | ||||
| GGTCCACACCCGCC–AGGAGGAAGATGTCA | 2 D | 1 | ||||
| GGTCCACACCCaCCgGAGGAGGAAGATGTCA | 2 S | 1 | ||||
Under lines indicate the target sites of ZFNs. Small letters and hyphen show the different and deleted nucleotides compared to the WT sequences, respectively.
S: substitution, D: deletion, I: insertion.
In vitro development of ZFN-injected mouse embryos.
| Target gene | No. (%) of embryos | ||||
| total | 2-cell | Blastocyst | |||
| Non-injected | 27 | 27 | (100) | 27 | (100) |
| Water-injected | 40 | 38 | (95) | 32 | (80) |
|
| 165 | 148 | (89.7) | 125 | (75.8) |
|
| 68 | 63 | (92.6) | 59 | (86.8) |
|
| 83 | 72 | (86.7) | 64 | (77.1) |
|
| 48 | 40 | (83.3) | 11 | (22.9) |
ZFN-induced site-directed mutations in new-born mouse.
| Target gene | 2-cell embryos transferred | Born | Mutated | Sequence of terget site | Modification(D, I) | Number of embryos |
|
| 95 | 22 | 5 |
| WT | 17 |
| A | 1 D | 1 | ||||
| A | 1 D | 1 | ||||
| A | 2 D | 1 | ||||
| A | 5 D | 1 | ||||
| A | 2 I | 1 | ||||
|
| 42 | 7 | 1 |
| WT | 6 |
| C | 5 D | 1 | ||||
|
| 40 | 8 | 1 |
| WT | 7 |
| A | 7 D | 1 | ||||
|
| 61 | 0 | 0 |
| WT | - |
Under lines indicate the target sites of ZFNs. Small letters and hyphen show the inserted and deleted nucleotids compared to the WT seuences, respectively.
D: deletion, I: insertion.